We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Multidirectional Radio Surgery Treats Brain Cancer

By HospiMedica International staff writers
Posted on 30 Oct 2009
A new study claims that stereotactic radiosurgery (SRS) is the preferred method of treating cancer patients with brain metastases.

Researchers at the University of Texas MD Anderson Cancer Center (Houston, TX, USA) randomly assigned 58 patients with one to three newly diagnosed brain metastases to SRS plus whole brain radiation therapy (WBRT) or SRS alone from Jan 2, 2001, to Sept 14, 2007. More...
The patients were stratified by recursive partitioning analysis class, number of brain metastases, and radioresistant histology. The randomization sequence was masked until assignation, at which point both clinicians and patients were made aware of the treatment allocation. The primary endpoint was neurocognitive function, objectively measured as a significant deterioration (5-point drop compared with baseline) in the Hopkins Verbal Learning Test-Revised (HVLT-R) total recall at 4 months.

The researchers reported that the trial was stopped by the data monitoring committee--according to early stopping rules--on the basis that there was a high probability (96%) that patients randomly assigned to receive SRS plus WBRT were significantly more likely to show a decline in learning and memory function at 4 months than patients assigned to receive SRS alone. At four months, there were four deaths (13%) in the group that received SRS alone, and eight deaths (29%) in the group that received SRS plus WBRT. On the other hand, 73% of patients in the SRS plus WBRT group were free from CNS recurrence at one year, compared with 27% of patients who received SRS alone. In the SRS plus WBRT group, one case of grade 3 toxicity was attributed to radiation treatment; in the group that received SRS, one case of grade 3 toxicity (aphasia) was attributed to radiation treatment; two cases of grade 4 toxicity in the group that received SRS alone were diagnosed as radiation necrosis. The study was published in the October 5, 2009, online edition of the Lancet Oncology.

"Despite this difference in recurrence rates, we would still advise against WBRT because the risks of learning dysfunction outweigh the benefits of freedom from progression,” said lead author Eric L. Chang, M.D., an associate professor in the department of radiation oncology. "With close monitoring, salvage resections or additional radiation can be performed as necessary and patients who receive SRS alone will fare better with their quality of life intact.”

Stereotactic surgery is a minimally invasive form of surgical intervention, which makes use of a three-dimensional (3D) coordinates system to locate small targets inside the body and to perform a surgical procedure on them. Guide bars in the x, y, and z directions (or alternatively, in polar coordinates) are fitted with high precision vernier scales that allow the neurosurgeon to position the point of a probe inside the brain through a small trephine hole in the skull at the calculated coordinates for the desired structure.

Related Links:
University of Texas MD Anderson Cancer Center



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.